SENSEX NIFTY

Drugs

Oct 31, 2014 at 11:01 | Source: PTI
An international organisation working for cancer affected people has asked the Obama administration not to pressurise India to reject a compulsory license on a drug for a rare form of leukaemia which would be a de facto endorsement of an excessive price.
Oct 29, 2014 at 16:51 | Source: CNBC-TV18
Discussing the companys results, GV Prasad co-chairman and CEO, DRL, said the quarter has been a flattish one on the back of high R&D expenses. He expects growth to return once launches start happening.
Oct 29, 2014 at 12:18 | Source: Moneycontrol.com
Mangalam Drugs & Organics Ltd has informed BSE that Mrs. Meenal Sukhani has been appointed as Additional Director on the Board of the Company with effect from October 21, 2014. She will be Non - executive director of the Company.
Oct 28, 2014 at 14:55 | Source: Moneycontrol.com
Consolidated net profit of the drug maker jumped 55 percent year-on-year to Rs 630 crore during the quarter led by growth in formulations, US and domestic businesses, and also due to higher other income and lower tax cost.
Oct 28, 2014 at 14:24 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on November 08, 2014, to transact the following items of business thereat: 1. To review the performance of the Company.
Oct 28, 2014 at 10:55 | Source: Moneycontrol.com
Parabolic Drugs has submitted a copy of minutes of the proceedings of the 18th Annual General Meeting (AGM) of the Company held on September 30, 2014.
Oct 22, 2014 at 19:05 | Source: Moneycontrol.com
Beryl Drugs has reported a sales total income from operations of Rs 3.33 crore and a net profit of Rs 0.15 crore for the quarter ended Sep '14
Oct 21, 2014 at 16:12 | Source: PTI
Terming the US as a high growth market for the company, the Mumbai-based firm said it aims to grow at around 25 percent in the world's largest drug market.
Oct 20, 2014 at 16:08 | Source: CNBC-TV18
The growth for the international generics, however, remain muted at about 9 percent due to higher base last year.
Oct 15, 2014 at 20:09 | Source: CNBC-TV18
NPPA had issued guidelines in May for regulating prices of non essential drugs. Subsequently, an order was passed in July for regulating prices of 108 non-essential drugs.
Messages on Drugs »

maximindia

Platinum Member

586 Followers

Ranbaxy Labs  

If one notice everyday USA approving many indian co`s formulation in many blockbuster drugs and naturally RBaxy and SUN is in t top of lists.Reasoning is not far to see that USA want Modi`s visit of USA become highflier and what make SUN/RBaxy combo approvals as forerunners as SUN is based

4.53 PM Jul 8th

Market Statistician

Platinum Member

10539 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.25. At 15:13 hrs, the share was quoting at Rs 10.19, up Rs 0.27, or 2.72%. See more

3.15 PM Jul 8th

Market Statistician

Platinum Member

10539 Followers

Aarey Drugs  

At 15:13 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 21.40 up 7.65%, with a huge increase in its volume of shares traded. Till now over 367,096 shares were traded as compared to its 5-day average of 114,854 shares.

3.15 PM Jul 8th

Market Statistician

Platinum Member

10539 Followers

Parenteral Drug  

At 15:14 hrs, Parenteral Drugs (India) was trading at Rs 33.80 up 4.32%, with a huge increase in its volume of shares traded. Till now over 448,621 shares were traded as compared to its 5-day average of 90,823 shares.

3.15 PM Jul 8th

Market Statistician

Platinum Member

10539 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.21. At 14:14 hrs, the share was quoting at Rs 10.25, up Rs 0.33, or 3.33%. See more

2.15 PM Jul 8th

Market Statistician

Platinum Member

10539 Followers

Aarey Drugs  

At 14:12 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.94 up 5.33%, with a huge increase in its volume of shares traded. Till now over 304,764 shares were traded as compared to its 5-day average of 114,854 shares.

2.15 PM Jul 8th

Market Statistician

Platinum Member

10539 Followers

Parenteral Drug  

At 14:13 hrs, Parenteral Drugs (India) was trading at Rs 35.20 up 8.64%, with a huge increase in its volume of shares traded. Till now over 392,958 shares were traded as compared to its 5-day average of 90,823 shares.

2.15 PM Jul 8th

madrasan

Silver Member

1 Followers

Shasun Pharma  

The company might be a beneficiary of the Sevelamer molecule drugs going off patent in the US. Shasun is expected to be one of the Active Pharmaceutical Ingredients (API) supplier of these drugs. The latest indication of these drugs going off patent is that one of the molecules Sevelamer Carbonate

12.48 PM Jul 8th

Market Statistician

Platinum Member

10539 Followers

Aarey Drugs  

At 12:14 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.83 up 4.78%, with a huge increase in its volume of shares traded. Till now over 256,745 shares were traded as compared to its 5-day average of 114,854 shares.

12.15 PM Jul 8th

Market Statistician

Platinum Member

10539 Followers

Parenteral Drug  

At 12:14 hrs, Parenteral Drugs (India) was trading at Rs 36.50 up 12.65%, with a huge increase in its volume of shares traded. Till now over 275,045 shares were traded as compared to its 5-day average of 90,823 shares.

12.15 PM Jul 8th

News across the web »
Oct 31, 2014 at 14:06 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.